Physician

Ali Ajam, MD

According to 2025 Medicare claims, Ali Ajam, MD (NPI: 1841313517) practices rheumatology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is OSU INTERNAL MEDICINE, LLC (NPI: 1740231448; TIN: 311369596) and primary practice location at 43016-3508. Ajam is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Ajam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 240 traditional Medicare patients, billed 402 HCPCS/CPT codes, and received $26,802 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,629 prescription claims across 236 beneficiaries totaling $700,295 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 3 records totaling $9,841. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $258,334 to $26,802. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $255,715 to $700,295. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	216	10,414	$258,334
2016	237	4,547	$102,865
2017	219	774	$35,413
2018	234	672	$33,532
2019	242	458	$32,126
2020	210	371	$25,668
2021	224	383	$33,686
2022	240	435	$31,550
2023	251	707	$34,342
2024	240	402	$26,802

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	122	979	$255,715
2016	143	1,206	$329,293
2017	163	1,501	$334,735
2018	174	1,515	$352,461
2019	182	1,475	$453,845
2020	172	1,614	$702,661
2021	189	1,657	$652,444
2022	229	1,581	$749,586
2023	236	1,698	$836,389
2024	236	1,629	$700,295

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	29	29	$105
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	20	20	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	171	230	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	11	11	$56

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	36	1,008	$266,261
Humira(Cf) Pen	Adalimumab	28	896	$189,406
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	373	24,461	$13,024
Mycophenolate Mofetil	Mycophenolate Mofetil	64	2,760	$8,243
Methotrexate	Methotrexate Sodium	174	10,521	$2,453

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$9,561	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$280	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ali Ajam, MD?

Tedicare shows public-source Medicare data for Ali Ajam, MD (NPI 1841313517), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Ajam, MD have ACO affiliation data?

Ali Ajam, MD is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Ali Ajam, MD?

Ali Ajam, MD is linked to OSU INTERNAL MEDICINE, LLC (billing NPI 1740231448) in the available physician profile data.

Does Ali Ajam, MD have Open Payments data?

Ali Ajam, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.